ClinicalTrials.Veeva

Menu

Efficacy of the ATLAS Medical Device on Pain in Patients With Low Back Pain Due to Lumbar Disc Disease (AmbuTract)

G

GCS Ramsay Santé pour l'Enseignement et la Recherche

Status

Terminated

Conditions

Lumbar Disc Disease

Treatments

Other: Mac Gill Pain Questionnaire
Other: Roland and Morris Disability Questionnaire
Other: Visual analog scale
Other: Quebec questionnaire

Study type

Interventional

Funder types

Other

Identifiers

NCT04585386
2020-A01625-34

Details and patient eligibility

About

Monocentric, comparative, randomized, controlled interventionnal study in 2 parallel groups, aiming to compare the efficacy of the ATLAS device with that of a standard lumbar belt on the reduction of pain felt in patients with subacute or chronic low back pain with lumbar disc disease.

Full description

The main expected benefit is a reduction in pain experienced in patients with subacute or chronic low back pain during and after wear. Consequently, an improvement in the quality of daily life is expected with a less significant impact of low back pain.

The main objective of the study is to compare the efficacy of the ATLAS medical device with a standard lumbar support belt in terms of immediate reduction of low back pain experienced in patients with subacute or chronic low back pain.

Enrollment

3 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient suffering from subacute (for 6 to 12 weeks) or chronic (> 3 months) lumbar pain;
  • Lumbar disc disease confirmed by Magnetic Resonance Imaging (MRI) less than 3 months old;
  • Patient with lumbar pain ≥ 40mm on the visual analogue scale (VAS) at inclusion;
  • Patient in whom a lumbar belt / restraint is considered for a short period to help resumption of activity;
  • Patient with internet and a camera (by phone or computer) and agreeing to use them as part of the study's teleconsultations;
  • Patient capable of understanding the information related to the study (absence of linguistic, psychological, cognitive problem, etc.), of reading the information leaflet, of completing questionnaires and agreeing to sign the consent form.

Exclusion criteria

  • Patient with neurological radicular or medullary deficits;
  • Patient presenting a postural problem with lateralized contracture;
  • Skin pathology in the trunk region and / or contusions and injuries by stretching the trunk;
  • History of spinal arthrodesis surgery;
  • History of cauda equina syndrome;
  • Patient treated by implanted neurostimulation;
  • Scoliosis with Cobb angle> 30 °;
  • History of recent fracture of the dorsolumbar spine (<3 months);
  • History of recent rib fracture (<3 months);
  • History of recent herniated disc surgery (<3 months);
  • Patient with diagnosed fracture osteoporosis;
  • Patient with heart or circulatory disease or respiratory failure;
  • Patient presenting with a tumor or infectious process of the vertebrae;
  • Pregnant or likely to be (of childbearing age, without effective contraception) or breastfeeding;
  • Patient participating in another clinical trial, or in a period of exclusion from another clinical trial;
  • Patient not beneficiary of a social security scheme.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

3 participants in 2 patient groups

ATLAS
Experimental group
Description:
Medical device named ATLAS which is an "active corset" (rigid lumbar restraint) and connected.
Treatment:
Other: Roland and Morris Disability Questionnaire
Other: Mac Gill Pain Questionnaire
Other: Quebec questionnaire
Other: Visual analog scale
Standard lumbar support belt
Active Comparator group
Description:
Standard lumbar support belt : LombaSkin® or Lombogib®
Treatment:
Other: Roland and Morris Disability Questionnaire
Other: Mac Gill Pain Questionnaire
Other: Quebec questionnaire
Other: Visual analog scale

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems